CAMPBELLVILLE, ON, Sept. 11 /CNW/ - NIR Diagnostics Inc. (TSX Venture: NID), a leading-edge developer of near-infrared medical instruments, today announced that Shaklee Corporation of Pleasanton, California, advised NIR Diagnostics on September 8, 2007 that it is Shaklee’s position that the conditions were not met that would entitle NIR Diagnostics to a $1,000,000 success fee in connection with the delivery of the in-vivo food supplement prototype device using NIR Diagnostics’ proprietary infrared technology, as stipulated in the strategic alliance agreement announced on August 9, 2006.
